Appointment of Dr Georg Hochwimmer as a Director

NEWS RELEASE 24-15 May 23, 2024


APPOINTMENT OF DR GEORG HOCHWIMMER AS A CHATHAM DIRECTOR

WELLINGTON, New Zealand - Chatham Rock Phosphate Limited (“CRP”) (TSXV: NZP, NZX: CRP,
Frankfurt Borse: 3GRE) is very pleased to advise that Munich based Dr Georg Hochwimmer
has today been appointed as a director. This is the logical next step in a close association with
Dr Hochwimmer which now spans eight years since our first meeting at the PDAC conference
in Toronto in 2016.

During that period Dr Hochwimmer has worked actively sourcing equity capital for Chatham
from his networks in Europe, Canada and elsewhere and he is presently our largest
shareholder in his own right.

Dr Hochwimmer operates General Research GmbH, a consulting company providing financial
analysis, corporate finance and investor relations advice. General Research is particularly
focused on emerging growth companies and Dr Hochwimmer has been a founding director of
several technology start-ups.

His PhD qualification, connections and business experience are welcome additions to an
already well-rounded Board and these attributes and his Europe location are particularly
relevant to Chatham’s target markets in that region.

For further information please contact:

Chris Castle
President and Chief Executive Officer
Chatham Rock Phosphate Limited
64 21 55 81 85 or chris@crpl.co.nz

Statements about the Company’s future expectations and all other statements in this press
release other than historical facts are “forward looking statements”. Such forward-looking
statements are based on numerous assumptions, and involve known and unknown risks,
uncertainties and other factors, including risks inherent in mineral exploration and
development, which may cause the actual results, performance, or achievements of the
Company to be materially different from any projected future results, performance, or
achievements expressed or implied by such forward-looking statements.

Neither the Exchange, its Regulation Service Provider (as that term is defined under the
policies of the Exchange), or New Zealand Exchange Limited has in any way passed upon the
merits of the above descried transaction and has neither approved nor disapproved of the
contents of this press release.